NEW YORK (GenomeWeb) – Vermillion said today that it is issuing a private placement that could raise around $10.7 million.

The placement consists of about 3.7 million shares of Vermillion common stock to be sold at $1.40 per share — the stock's closing price on Feb. 10 — as well as warrants to purchase up to 2.8 million shares of common stock for $1.80 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.